Marie‐Hélène Delfau‐Larue

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

Olivier Hermine, Eva Hoster, Jan Walewski et al. · The Lancet · 2016 · 401 citations

Medicine, Immunology, Oncology +17

Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type

Yen‐Lin Huang, Aurélien de Reyniès, Laurence de Leval et al. · Blood · 2009 · 311 citations · Full text

Life Sciences, Molecular Biology, Oncology +11

Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

Paul Evans, Ch Pott, Patricia J.T.A. Groenen et al. · Leukemia · 2006 · 297 citations

Life Sciences, Hematology, Immunology +11

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

Christiane Pott, Eva Hoster, Marie‐Hélène Delfau‐Larue et al. · Blood · 2009 · 269 citations · Full text

Medicine, Hematology, Oncology +12

Peripheral T-cell Lymphomas With a Follicular Growth Pattern are Derived From Follicular Helper T Cells (TFH) and may Show Overlapping Features With Angioimmunoblastic T-cell Lymphomas

Yenlin Huang, Jehan Dupuis, Berthold Streubel et al. · The American Journal of Surgical Pathology · 2009 · 210 citations

Medicine, Hematology, Pathology +16